Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

3337 Press Releases
DateTitleCompany
24 Aug 15 Roche to acquire Kapa Biosystems to strengthen next-generation sequencing product offerings Roche,
Published by
Pharmiweb.com
24 Aug 15 Roche purchases innovative nucleic acid purification technology from Lumora to enhance sample preparation for sequencing Roche,
Published by
Pharmiweb.com
24 Aug 15 Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015 Pfizer,
Published by
Pharmiweb.com
24 Aug 15 Pfizer Receives Clearance from U.S. Federal Trade Commission for Hospira Acquisition Pfizer,
Published by
Pharmiweb.com
24 Aug 15 Pfizer Announces Positive Topline Results Of Two Phase 3 Studies Of TRUMENBA® (Meningococcal Group B Vaccine) Pfizer,
Published by
Pharmiweb.com
24 Aug 15 Pfizer Announces European Medicines Agency Validates Marketing Authorization Application for IBRANCE® (palbociclib) in Combination with Endocrine Therapy for the Treatment of HR+/HER2- Metastatic Breast Cancer Pfizer,
Published by
Pharmiweb.com
24 Aug 15 New Study By The Scripps Research Institute And Janssen Makes Major Advance Toward More Effective, Long-Lasting Flu Vaccine The Scripps Research Institute,
Published by
Pharmiweb.com
24 Aug 15 RetroSense Therapeutics’ Lead Gene Therapy Candidate Gets FDA Clearance to Proceed to First-in-Human Clinical Trials RetroSense Therapeutics,
Published by
Pharmiweb.com
24 Aug 15 Epizyme Announces Acceptance of Investigational New Drug Application for Tazemetostat in Patients with INI1-Negative Tumors or Synovial Sarcoma Epizyme,
Published by
Pharmiweb.com
24 Aug 15 MMJ PhytoTech Ltd (ASX:MMJ) To Commence Phase 1 Clinical Study Late 2015 MMJ PhytoTech,
Published by
Pharmiweb.com
24 Aug 15 Vaxart, Inc. Announces Lancet ID Publication Of Influenza Tablet Vaccine Phase 1 Results Vaxart,
Published by
Pharmiweb.com
24 Aug 15 Spotlight Innovation subsidiary Celtic Biotech prepares to start Part 2 of Phase I Intravenous Crotoxin clinical study post completion of Part 1 Spotlight Innovation,
Published by
Pharmiweb.com
24 Aug 15 Portage's Biohaven's lead drug candidate clears FDA Investigational New Drug Application (IND) review and clinical studies to begin Portage Biohaven,
Published by
Pharmiweb.com
24 Aug 15 RedHill Biopharma Announces Peer-Reviewed Publication Demonstrating Therapeutic Potential of ABC294640 (YELIVA(TM)) in Prostate Cancer RedHill Biopharma,
Published by
Pharmiweb.com
24 Aug 15 HSRx Group's Acne Treatment Product in Clinical Trial, Aims to Rapidly Reduce Redness and Intensity of Breakouts HSRx Group,
Published by
Pharmiweb.com
24 Aug 15 Collegium Publishes Data From Xtampza(TM) ER Phase 3 Clinical Trial in the Journal PAIN Collegium Pharmaceutical,
Published by
Pharmiweb.com
24 Aug 15 Galena Biopharma Announces Independent Data Safety Monitoring Committee Recommends Reduction of Cardiac Toxicity Monitoring for NeuVax(TM) PRESENT Trial Galena Biopharma,
Published by
Pharmiweb.com
24 Aug 15 MTG Biotherapeutics Announces that MTG-201 was Granted Orphan Drug Designation by the US FDA for the Treatment of Malignant Mesothelioma MTG Biotherapeutics,
Published by
Pharmiweb.com
24 Aug 15 Regen BioPharma, Inc. BORIS Gene Silencing Technology Successfully Utilized by Independent Researchers to Kill Breast Cancer and Colon Cancer Stem Cells Regen BioPharma,
Published by
Pharmiweb.com
24 Aug 15 Alkermes Provides Update on FDA Review of ARISTADA™ for the Treatment of Schizophrenia Alkermes,
Published by
Pharmiweb.com
24 Aug 15 FYCOMPA® (perampanel) CIII Demonstrates a Significant Reduction in Primary Generalized Tonic-Clonic (PGTC) Seizure Frequency in Phase 3 Trial of Patients with Epilepsy Age 12 and Older Eisai,
Published by
Pharmiweb.com
24 Aug 15 U.S. FDA Accepts BOTOX® (onabotulinumtoxinA) Resubmission for the Treatment of Lower Limb Spasticity in Adults Allergan,
Published by
Pharmiweb.com
24 Aug 15 Allergan Issues Voluntary Nationwide Recall in the U.S. of Specific Lots of REFRESH® Lacri-Lube® Allergan,
Published by
Pharmiweb.com
24 Aug 15 Vital Therapies Announces That Topline Results of VTI-208 Fail to Achieve Primary or Secondary Endpoints of Improvement in Overall Survival Pre-Specified Exploratory Subset Analyses Suggest Efficacy Trends Vital Therapies,
Published by
Pharmiweb.com
24 Aug 15 New Drug Classes Re-shaping the Landscape for Glycemic Control Greystone Research Associates
24 Aug 15 Portage's Biohaven's lead drug candidate clears FDA Investigational New Drug Application (IND) review and clinical studies to begin Portage Biotech Inc.,
Published by
PR Newswire
24 Aug 15 TiGenix announces Cx601 meets primary endpoint in pivotal Phase III trial TiGenix,
Published by
Pharmiweb.com
24 Aug 15 Accutest Expands Into Latin American Countries to Support Drug Development Accutest Research Laboratories (I) Pvt. Ltd.,
Published by
PR Newswire
24 Aug 15 Real World ETNA Registries of New Once-Daily LIXIANA?® (edoxaban) Start in Europe Daiichi Sankyo Europe GmbH,
Published by
PR Newswire
23 Aug 15 Seattle Genetics Announces FDA Regular Approval of ADCETRIS® (Brentuximab Vedotin) for Classical Hodgkin Lymphoma Patients at High Risk of Relapse or Progression as Post-Autologous Hematopoietic Stem Cell Transplantation Consolidation Seattle Genetics,
Published by
Pharmiweb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.